La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
SHL Aperçu des actions
Siemens Healthineers AG, par l'intermédiaire de ses filiales, développe, fabrique et vend une gamme de produits et de services diagnostiques et thérapeutiques aux prestataires de soins de santé du monde entier.
| Score flocon de neige | |
|---|---|
| Évaluation | 3/6 |
| Croissance future | 2/6 |
| Performances passées | 5/6 |
| Santé financière | 2/6 |
| Dividendes | 3/6 |
Siemens Healthineers AG Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | €51.50 |
| Plus haut sur 52 semaines | €58.14 |
| Plus bas sur 52 semaines | €44.39 |
| Bêta | 0.70 |
| 1Variation sur 1 mois | -3.88% |
| Variation sur 3 mois | -3.59% |
| Variation sur 1 an | 13.24% |
| 3Variation sur 3 ans | -15.16% |
| Variation sur 5 ans | 45.30% |
| Évolution depuis l'introduction en bourse | 70.53% |
Nouvelles et mises à jour récentes
Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jul 22
Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Recent updates
Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jul 22Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Dec 18Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 24Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price
Jun 08Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Mar 03Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Feb 13It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year
Feb 09Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jan 27Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Jan 09Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95
Dec 18Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Nov 17An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued
Nov 01Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?
Oct 01Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 05Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth
Jun 24Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?
Apr 18We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now
Feb 08Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Jan 16I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut
Dec 05Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Sep 06Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jul 26We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt
Jun 01A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)
Apr 20Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?
Mar 12Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend
Feb 24Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date
Feb 09
How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?
Jan 29Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Jan 14Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?
Dec 30Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Dec 15Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?
Nov 30Rendement pour les actionnaires
| SHL | DE Medical Equipment | DE Marché | |
|---|---|---|---|
| 7D | 2.4% | 2.7% | 3.3% |
| 1Y | 13.2% | 7.5% | 4.7% |
Rendement vs Industrie: SHL exceeded the German Medical Equipment industry which returned 7.3% over the past year.
Rendement vs marché: SHL exceeded the German Market which returned 4.1% over the past year.
Volatilité des prix
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 2.9% |
| Medical Equipment Industry Average Movement | 4.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.6% |
Cours de l'action stable: SHL has not had significant price volatility in the past 3 months.
Volatilité au fil du temps: SHL's weekly volatility (3%) has been stable over the past year.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| n/a | 71,800 | Bernd Montag | www.siemens-healthineers.com |
Siemens Healthineers AG, par l'intermédiaire de ses filiales, développe, fabrique et vend une gamme de produits et de services diagnostiques et thérapeutiques aux prestataires de soins de santé du monde entier. Elle opère à travers quatre segments : Imagerie, Diagnostic, Varian et Thérapies avancées. Le segment Imagerie propose des systèmes d'imagerie par résonance magnétique, de tomographie assistée par ordinateur, de radiographie, d'imagerie moléculaire et d'échographie.
Siemens Healthineers AG Résumé des fondamentaux
| SHL statistiques fondamentales | |
|---|---|
| Capitalisation boursière | €57.46b |
| Bénéfices(TTM) | €1.86b |
| Recettes(TTM) | €22.09b |
30.8x
Ratio P/E2.6x
Ratio P/SLe site SHL est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| SHL compte de résultat (TTM) | |
|---|---|
| Recettes | €22.09b |
| Coût des recettes | €13.74b |
| Marge brute | €8.35b |
| Autres dépenses | €6.49b |
| Les revenus | €1.86b |
Derniers bénéfices déclarés
Jun 30, 2024
Prochaine date de publication des résultats
Nov 06, 2024
| Résultat par action (EPS) | 1.67 |
| Marge brute | 37.81% |
| Marge bénéficiaire nette | 8.43% |
| Ratio dettes/capitaux propres | 92.2% |
Quelles ont été les performances à long terme de SHL?
Voir les performances historiques et les comparaisons